MedPath
HSA Approval

Plerixafor-AFT solution for injection 24 mg/1.2 mL

SIN17147P

Plerixafor-AFT solution for injection 24 mg/1.2 mL

Plerixafor-AFT solution for injection 24 mg/1.2 mL

December 12, 2024

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

SUBCUTANEOUS

Medical Information

L03AX16

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

Sichuan Huiyu Pharmaceutical Co., Ltd.

Active Ingredients

PLERIXAFOR

24 mg/1.2 mL

Plerixafor

Documents

Package Inserts

PLERIXAFOR-AFT SOLUTION FOR INJECTION PI.pdf

Approved: December 12, 2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.